newsfilter
← Latest News
GlobeNewswire·

NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference

PITTSBURGH, Sept. 28, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase"), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, announce